518 related articles for article (PubMed ID: 10325895)
1. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
van Noord JA; Schreurs AJ; Mol SJ; Mulder PG
Thorax; 1999 Mar; 54(3):207-12. PubMed ID: 10325895
[TBL] [Abstract][Full Text] [Related]
2. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M; Pieters WR; Schlösser NJ; Steinmetz KO
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[TBL] [Abstract][Full Text] [Related]
3. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
Chuchalin A; Jacques L; Frith L
Clin Drug Investig; 2008; 28(3):169-81. PubMed ID: 18266402
[TBL] [Abstract][Full Text] [Related]
4. Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.
Boonsawat W; Goryachkina L; Jacques L; Frith L
Clin Drug Investig; 2008; 28(2):101-11. PubMed ID: 18211118
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
6. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
7. Salmeterol/fluticasone propionate (50/250 microg) combination is superior to double dose fluticasone (500 microg) for the treatment of symptomatic moderate asthma.
Bergmann KC; Lindemann L; Braun R; Steinkamp G
Swiss Med Wkly; 2004 Jan; 134(3-4):50-8. PubMed ID: 14745658
[TBL] [Abstract][Full Text] [Related]
8. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
Baraniuk J; Murray JJ; Nathan RA; Berger WE; Johnson M; Edwards LD; Srebro S; Rickard KA
Chest; 1999 Sep; 116(3):625-32. PubMed ID: 10492263
[TBL] [Abstract][Full Text] [Related]
9. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A; Jarvis B
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[TBL] [Abstract][Full Text] [Related]
10. Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma.
Van den Berg NJ; Ossip MS; Hederos CA; Anttila H; Ribeiro BL; Davies PI
Pediatr Pulmonol; 2000 Aug; 30(2):97-105. PubMed ID: 10922131
[TBL] [Abstract][Full Text] [Related]
11. Salmeterol/fluticasone propionate combination therapy 50/250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma.
Jenkins C; Woolcock AJ; Saarelainen P; Lundback B; James MH
Respir Med; 2000 Jul; 94(7):715-23. PubMed ID: 10926345
[TBL] [Abstract][Full Text] [Related]
12. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group.
Condemi JJ; Goldstein S; Kalberg C; Yancey S; Emmett A; Rickard K
Ann Allergy Asthma Immunol; 1999 Apr; 82(4):383-9. PubMed ID: 10227337
[TBL] [Abstract][Full Text] [Related]
13. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M
Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220
[TBL] [Abstract][Full Text] [Related]
14. Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease.
Vestbo J; Pauwels R; Anderson JA; Jones P; Calverley P;
Thorax; 2005 Apr; 60(4):301-4. PubMed ID: 15790985
[TBL] [Abstract][Full Text] [Related]
15. The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma.
Ringdal N; Eliraz A; Pruzinec R; Weber HH; Mulder PG; Akveld M; Bateman ED;
Respir Med; 2003 Mar; 97(3):234-41. PubMed ID: 12645830
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
Lee YS; Lin HC; Huang CD; Lee KY; Liu CY; Yu CT; Wang CH; Kuo HP
Chang Gung Med J; 2011; 34(4):382-94. PubMed ID: 21880193
[TBL] [Abstract][Full Text] [Related]
17. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma.
Bateman ED; Silins V; Bogolubov M
Respir Med; 2001 Feb; 95(2):136-46. PubMed ID: 11217910
[TBL] [Abstract][Full Text] [Related]
18. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
[TBL] [Abstract][Full Text] [Related]
19. Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma.
Ind PW; Dal Negro R; Colman NC; Fletcher CP; Browning D; James MH
Respir Med; 2003 May; 97(5):555-62. PubMed ID: 12735675
[TBL] [Abstract][Full Text] [Related]
20. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
Kavuru M; Melamed J; Gross G; Laforce C; House K; Prillaman B; Baitinger L; Woodring A; Shah T
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1108-16. PubMed ID: 10856143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
